According to a new report North America Spirulina Market, published by KBV research, the North America Spirulina Market would witness market growth of 9.9% CAGR during the forecast period (2019-2025).
The USA market dominated the North America Cosmetics Market by Region in 2018, growing at a CAGR of 11.6 % during the forecast period. The Canada market is expected to witness a CAGR of 12.5% during (2019 - 2025). Additionally, The Mexico market is expected to witness a CAGR of 14.7% during (2019 - 2025).
The Powder market dominated the North America Spirulina Market by Drug Formulation in 2018, growing at a CAGR of 9.2 % during the forecast period. The Tablet & Capsule market is expected to witness highest CAGR of 9.4% during (2019 - 2025).
The Arthrospira Platensis market dominated the Canada Spirulina Market by Type in 2018, thereby, achieving a market value of $27.6 Million by 2025, growing at a CAGR of 8.9 % during the forecast period. The Arthrospira Maxima market is expected to witness a CAGR of 12.6% during (2019 - 2025).
Full Report: https://www.kbvresearch.com/north-america-spirulina-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Cyanotech Corporation, DIC Corporation, Chr. Hansen Holding A/S, Algenol, LLC, Prolgae Spirulina Supplies Pvt. Ltd., Sensient Technologies Corporation, DDW, Inc., GNC Holdings, Inc., NOW Foods, Inc. and Sunrise Nutrachem Group Co. Ltd.
By Type
By Application
By Drug Formulation
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
